P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO

[ad_1] LEUVEN, Belgium, May 2, 2023 /PRNewswire/ — P95 BV, a global provider of epidemiology and clinical research solutions with a focus on vaccines and infectious diseases, today announced a…